Literature DB >> 12892861

Apathy in schizophrenia: clinical correlates and association with functional outcome.

Michael Kiang1, Bruce K Christensen, Gary Remington, Shitij Kapur.   

Abstract

Apathy is considered one of the negative symptoms of schizophrenia, but its natural history and relationship to other clinical characteristics have not been systematically studied. The purpose of this cross-sectional study was to measure the level of apathy in schizophrenia and its relation to other symptoms and functional outcome. Twenty-eight patients with schizophrenia, and receiving antipsychotic treatment, were assessed with the Apathy Evaluation Scale (AES). The mean level of apathy of patients with schizophrenia, as rated by the AES, was significantly higher than that of matched healthy control subjects. In the patients, apathy was not significantly correlated with positive symptoms or depressive symptoms. It was significantly correlated with the item "emotional withdrawal" on the negative subscale of the Positive and Negative Syndrome Scale (PANSS), but was not correlated with the overall negative subscale score. Apathy was more highly associated with functional outcome than were other symptom measures, and it was independently associated with functional outcome above and beyond other negative symptoms. It was not associated with observed interest in playing a video game or performance on a simulated clerical task.

Entities:  

Mesh:

Year:  2003        PMID: 12892861     DOI: 10.1016/s0920-9964(02)00433-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  29 in total

1.  An appraisal of the psychometric properties of the Clinician version of the Apathy Evaluation Scale (AES-C).

Authors:  Diana E Clarke; Robert Van Reekum; Jigisha Patel; Martine Simard; Everlyne Gomez; David L Streiner
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

Review 2.  Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment.

Authors:  Thomas N Chase
Journal:  Neurotox Res       Date:  2010-05-15       Impact factor: 3.911

3.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

4.  Striatal dopamine D2 receptors regulate effort but not value-based decision making and alter the dopaminergic encoding of cost.

Authors:  Ina Filla; Matthew R Bailey; Elke Schipani; Vanessa Winiger; Chris Mezias; Peter D Balsam; Eleanor H Simpson
Journal:  Neuropsychopharmacology       Date:  2018-07-20       Impact factor: 7.853

5.  A novel strategy for dissecting goal-directed action and arousal components of motivated behavior with a progressive hold-down task.

Authors:  Matthew R Bailey; Greg Jensen; Kathleen Taylor; Chris Mezias; Cait Williamson; Rae Silver; Eleanor H Simpson; Peter D Balsam
Journal:  Behav Neurosci       Date:  2015-06       Impact factor: 1.912

6.  The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia.

Authors:  Silvana Galderisi; Alessandro Rossi; Paola Rocca; Alessandro Bertolino; Armida Mucci; Paola Bucci; Paola Rucci; Dino Gibertoni; Eugenio Aguglia; Mario Amore; Antonello Bellomo; Massimo Biondi; Roberto Brugnoli; Liliana Dell'Osso; Diana De Ronchi; Gabriella Di Emidio; Massimo Di Giannantonio; Andrea Fagiolini; Carlo Marchesi; Palmiero Monteleone; Lucio Oldani; Federica Pinna; Rita Roncone; Emilio Sacchetti; Paolo Santonastaso; Alberto Siracusano; Antonio Vita; Patrizia Zeppegno; Mario Maj
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 7.  A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Authors:  Lauren Luther; Ruth L Firmin; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Clin Psychol Rev       Date:  2018-04-07

Review 8.  Neurocognitive mechanisms of conceptual processing in healthy adults and patients with schizophrenia.

Authors:  Tatiana Sitnikova; Christopher Perrone; Donald Goff; Gina R Kuperberg
Journal:  Int J Psychophysiol       Date:  2009-12-07       Impact factor: 2.997

9.  Predictive factors of social functioning in patients with schizophrenia: exploration for the best combination of variables using data mining.

Authors:  Sung-Man Bae; Seung-Hwan Lee; Young-Min Park; Myung-Ho Hyun; Hiejin Yoon
Journal:  Psychiatry Investig       Date:  2010-04-06       Impact factor: 2.505

10.  Apathy, poor verbal memory and male gender predict lower psychosocial functioning one year after the first treatment of psychosis.

Authors:  Ann Faerden; Elizabeth Ann Barrett; Ragnar Nesvåg; Svein Friis; Arnstein Finset; Stephen R Marder; Joseph Ventura; Ole A Andreassen; Ingrid Agartz; Ingrid Melle
Journal:  Psychiatry Res       Date:  2013-03-13       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.